The Incyte ORR of 30-35% is for some other solid cancers (not...

The Incyte ORR of 30-35% is for some other solid cancers (not melanoma). If our equivalent STORM combo with keytruda gives the same or better results then VLA will re-rate since lung cancer in particular is a massive market.

Theoretically we are recruiting for 80 patients with no need to do it in stages, so it will be very interesting to learn soon how well the recruiting is progressing, not to mention early indications of responses.